Skip to main content
OpenTrials
Completed

NCT Number: NCT05083442

Low-level Laser and Lifestyle Modifications

The purpose of this research study is to evaluate the effectiveness of Low Level Laser Therapy in combination with Lifestyle Modifications in helping people reduce the extra weight and size in the central body region

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

About this study

Subjects will undergo Low Level Laser Therapy or Sham (placebo) treatments while incorporating lifestyle modifications through of wellness coaching.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • have a BMI 25-39.9 kg/m2
  • be able to participate fully in all aspects of the study; and
  • have understood and signed study informed consent

Exclusion criteria

  • have used weight loss medications or participated in a weight loss program within the past 30 days
  • are currently taking medications or supplements known to affect weight, such as insulin or sulfonylurea, prednisone or garcinia cambrogia
  • have had weight fluctuations of 5 pounds or more in the past month
  • have an implanted device (including pacemaker or lap band) in the targeted area of LLLT
  • have a known active eating disorder
  • have a known, active, untreated clinically significant psychiatric condition (alcohol or substance abuse, psychosis, bipolar disorder, or depression)
  • have used an investigational drug within 30 days of study enrollment
  • Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the low-level laser therapy treatment phase and are unwilling to use a reliable form of contraception. Acceptable forms include:
  • Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants
  • Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm)
  • Intrauterine device (IUD)
  • Total hysterectomy or tubal ligation
  • Abstinence (no sex)
  • have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease
  • have current uncontrolled hypertension (systolic > 160 mm Hg or diastolic > 95 mm Hg) documented on 2 separate occasions
  • have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as uncontrolled diabetes type 2) or active cancer or are within 1 year of cancer remission
  • surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc. within 12 months prior to enrollment
  • medical, physical, or other contraindications for body sculpting/weight loss
  • any medical condition known to affect weight levels and/or to cause bloating or swelling
  • a diagnosis of, and/or taking medication for, irritable bowel syndrome
  • active infection, wound or other external trauma to the areas to be treated with the laser
  • known photosensitivity disorder
  • current active cancer or currently receiving treatment for cancer; or
  • have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence

Treatment and study plan

Low Level Laser Therapy

Device

Non-surgical cosmetic treatment which can be used by individuals intending to reduce size of the mid-section

Sham (placebo)

Other

Use of sham (placebo) option

Primary outcomes

  1. Change in Fat Mass From Baseline to 6 Weeks

    Time frame: 6 weeks

    The change in fat mass from baseline to the end of treatments at 6 weeks

  2. Change in Waist Circumference From Baseline to 6 Weeks

    Time frame: 6 weeks

    The change in waist circumference from baseline to the end of treatments at 6 weeks

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Erchonia Corporation

Registry information

Official study title

A Feasibility Study Addressing the Adjunct Use of Low-Level Laser to Mayo Lifestyle Modification Education and Wellness Coaching for Reducing Central Adiposity and Fat Mass

Acronym: LLLT

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Oct 19, 2021
Registry last updated
Apr 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.